Coronary heart disease secondary prevention depression: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Coronary heart disease}} {{CMG}} == Overview == ==Beta Blockers== ===ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Depression Man...")
 
No edit summary
Line 4: Line 4:


== Overview ==
== Overview ==
==Beta Blockers==
==Depression==
===ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Depression Management (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934  }} </ref>===
===ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Depression Management (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934  }} </ref>===



Revision as of 17:14, 11 October 2012

Coronary heart disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Coronary heart disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening and Risk Stratification

Natural History, Complications and Prognosis

Diagnosis

Pretest Probability

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Coronary heart disease secondary prevention depression On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coronary heart disease secondary prevention depression

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coronary heart disease secondary prevention depression

CDC on Coronary heart disease secondary prevention depression

Coronary heart disease secondary prevention depression in the news

Blogs on Coronary heart disease secondary prevention depression

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Coronary heart disease secondary prevention depression

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Depression

ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Depression Management (DO NOT EDIT) [1]

Class IIa

"1. For patients with recent coronary artery bypass graft surgery or myocardial infarction, it is reasonable to screen for depression if patients have access to case management, in collaboration with their primary care physician and a mental health specialist. (Level B)"

Class IIb

"1. Treatment of depression has not been shown to improve cardiovascular disease outcomes but may be reasonable for its other clinical benefits (Level C)"

References

  1. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.


Template:WikiDoc Sources